BCAL Diagnostics introduces multi-cancer test in Sydney, Melbourne
Full story: https://grafa.com/en/news/australia/bcal-diagnostics-introduces-multi-cancer-test-in-sydney-melbourne BCAL Diagnostics introduced the Avantect blood-based test in Australia to screen for eight cancer types. The company's stock remained unchanged following the product rollout announcement. The commercialisation strategy targets national expansion following initial rollouts in Sydney and Melbourne. BCAL Diagnostics (ASX:BDX) has commenced the Australian rollout of the Avantect Multi-Cancer blood-based diagnostic test in Sydney and Melbourne. The phased launch provides local patients access to non-invasive testing capable of detecting signals across eight distinct cancer types alongside organ-of-origin indicators. BCAL CEO Anne-Louise Arnett said, “The direction of cancer diagnost
Full story: https://grafa.com/en/news/australia/aurum-resources-raises-52-5m-for-project Aurum Resources secured $52.5 million in firm commitments through a single-tranche institutional placement to fund its Boundiali Project. The placement was completed at an issue price of $0.55 per share, bringing the company’s expected total cash balance to $95 million. Capital raised will accelerate early development, site access construction, land acquisition, and ongoing exploration drilling. Aurum Resources (ASX:AUE) has secured $52.5 million in firm commitments via a single-tranche institutional placement of roughly 95.5 million new shares to fund development at its Boundiali Gold Project. The issue price of $0.55 per share represents a single-tranche structure, with existing and new strategic inv
Full story: https://grafa.com/en/news/australia/qmines-intersects-broad-copper-zone-in-queensland QMines reported broad copper mineralisation at its Mt Chalmers Project. The announcement supported a 3.13% rise in the company's share price. Assays are pending for 19 holes as part of a 10,000m drilling campaign. QMines (ASX:QML) has intersected a 44m zone of copper mineralisation at its Mt Chalmers open pit in Queensland. The drill results build on the company's continuous exploration efforts aimed at expanding its regional resource footprint. QMines Exploration Manager, Tom Bartschi, said, “The 44m intersection in 26MCRD005 is a strong result, particularly the higher-grade copper intervals within it, while 26MCDD011 is also encouraging given the hole ended in mineralisation and remains unte
Strike Energy selects preferred West Erregulla processing pathway
Full story: https://grafa.com/en/news/australia/strike-energy-selects-preferred-west-erregulla-processing-pathway Strike Energy established a processing agreement with Hancock Energy for the West Erregulla Gas Project. The transaction secures a target processing capacity net to Strike of 43.5 terajoules per day. The agreement establishes Hancock Energy’s Belisama gas processing facility as the preferred development pathway. Strike Energy (ASX:STX) has chosen Hancock Energy's Belisama Gas Processing Facility as its preferred processing pathway for the West Erregulla Project. The selection provides a clear operational framework compared to earlier standalone processing concepts considered by the joint venture. The agreement targets a processing capacity net to Strike of 43.5 terajoules per d
Full story: https://grafa.com/en/news/australia/dimerix-draws-down-17m-funding-facility Dimerix has drawn down $17 million under its non-dilutive debt facility. The funding extends the company's financial runway without diluting existing shareholder equity. Capital will directly support key clinical programmes, including the ACTION3 Phase 3 trial. Dimerix (ASX:DXB) has drawn down $17 million under a non-dilutive debt facility to fund its key clinical pipeline. The drawdown represents 50% of the overall $34 million facility that the business secured from Australian and United States lenders. "The receipt of these funds further strengthens Dimerix's financial position and supports the continued execution of our key value-driving programmes, including the ACTION3 Phase 3 study of DMX-200 and
Full story: https://grafa.com/en/news/australia/myer-posts-276-5m-loss-as-impairments-hit Myer Holdings reported a full-year statutory loss of $276.5 million. Sales grew to $4.1 billion, but the stock fell after missing profit expectations. Management points to consumer weakness and high cost-of-living pressures as key drivers. Department store retailer Myer (ASX:MYR) reported a full-year statutory loss of $276.5 million after taking a major non-cash impairment charge. The result marked a significant downturn compared to the $211 million loss recorded in the prior financial year. "Consistent with the trends we observed in June and July, trading through the early part of FY27 has remained uneven, with softer conditions experienced in August followed by improving trading momentum through Sep
Australian Gold and Copper intersects zinc gold deposit
Full story: https://grafa.com/en/news/australia/australian-gold-and-copper-intersects-zinc-gold-deposit Australian Gold and Copper has confirmed broad zinc-rich mineralisation with consistent gold across multiple drill holes at the Northern Evergreen prospect. The news follows a 21-hole reverse circulation drilling programme testing shallow extensions of drill hole 26DDBR017. Australian Gold and Copper stated the ongoing programme aims to expand its mineral footprint across the South Cobar Basin. Australian Gold and Copper (ASX:AGC) has intersected broad zinc-rich mineralisation carrying consistent gold grades across multiple drill holes at its Northern Evergreen deposit. The discovery follows earlier step-out drilling at the site, which had previously returned shallow high-grade intercept
Full story: https://grafa.com/en/news/australia/nufarm-targets-380m-earnings-for-fy26 Nufarm projects FY26 underlying EBITDA between $370 million and $380 million, representing 25% growth at the midpoint. Leverage is expected to fall from 2.7 times to 2.0 times by September. The company is executing factory closures and product rationalisation to secure $50 million in run-rate cost savings by the end of FY27. Agricultural chemical company Nufarm (ASX:NUF) expects its FY26 underlying EBITDA to reach between $370 million and $380 million. The projected earnings represent an approximate 25% increase compared to the prior corresponding period, driven by growth in hybrid seeds and Omega-3 platforms. Secondary operational details include plans to shut down its manufacturing facility in Alsip in
Full story: https://grafa.com/en/news/australia/tuas-full-year-net-profit-jumps-to-28-7m Tuas recorded a full-year net profit after tax of S$26 million, up from S$6.9 million last year. The company's mobile subscriber base expanded to 1.5 million, driving annual revenue up to S$187.6 million. Tuas acknowledged the intermittent use of unauthorised spectrum while setting aside up to $30 million for cybersecurity. Tuas (ASX:TUA) reported a statutory net profit after tax of S$26 million for the year ended July 31, driven by strong subscriber growth across its mobile and broadband segments. The underlying financial expansion represented a substantial jump from the preceding year when the telecommunications company generated S$6.9 million in net profit on S$151.3 million in revenue. "Simba has b
IAG to seek public benefits approval for RAC alliance
Full story: https://grafa.com/en/news/australia/iag-to-seek-public-benefits-approval-for-rac-alliance Insurance Australia Group will apply for public benefits approval following an Australian Competition and Consumer Commission merger determination. The ACCC determined in Phase 2 that the proposed alliance with the Royal Automobile Club of Western Australia should not proceed on competition grounds. IAG will pursue a public benefits determination over approximately 50 business days to secure regulatory clearance for the partnership. Insurance Australia Group (ASX:IAG) announced it will make a public benefits application to progress its proposed alliance with the Royal Automobile Club of Western Australia after the Australian Competition and Consumer Commission issued a Phase 2 determinatio